newsfilter
← Latest News
GlobeNewswire·

First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi

BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted,